Red Door Wealth Management LLC Increases Stock Holdings in UnitedHealth Group Incorporated (NYSE:UNH)

Red Door Wealth Management LLC boosted its position in UnitedHealth Group Incorporated (NYSE:UNH - Free Report) by 8.3% during the 1st quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 19,468 shares of the healthcare conglomerate's stock after purchasing an additional 1,496 shares during the quarter. UnitedHealth Group comprises 1.5% of Red Door Wealth Management LLC's investment portfolio, making the stock its 17th biggest position. Red Door Wealth Management LLC's holdings in UnitedHealth Group were worth $10,196,000 at the end of the most recent reporting period.

A number of other hedge funds have also recently made changes to their positions in UNH. Citizens National Bank Trust Department lifted its position in UnitedHealth Group by 1.0% during the first quarter. Citizens National Bank Trust Department now owns 17,886 shares of the healthcare conglomerate's stock valued at $9,368,000 after purchasing an additional 170 shares during the last quarter. Fort Washington Investment Advisors Inc. OH lifted its holdings in shares of UnitedHealth Group by 0.3% during the 1st quarter. Fort Washington Investment Advisors Inc. OH now owns 530,103 shares of the healthcare conglomerate's stock worth $277,641,000 after acquiring an additional 1,465 shares during the last quarter. Sherbrooke Park Advisers LLC bought a new position in UnitedHealth Group in the fourth quarter valued at $515,000. Full Sail Capital LLC lifted its stake in UnitedHealth Group by 2.1% during the fourth quarter. Full Sail Capital LLC now owns 1,612 shares of the healthcare conglomerate's stock worth $815,000 after purchasing an additional 33 shares during the last quarter. Finally, Soros Fund Management LLC bought a new position in shares of UnitedHealth Group during the 4th quarter valued at about $39,413,000. 87.86% of the stock is currently owned by hedge funds and other institutional investors.

Insider Buying and Selling

In related news, CEO Stephen J. Hemsley bought 86,700 shares of the company's stock in a transaction on Friday, May 16th. The shares were acquired at an average cost of $288.57 per share, with a total value of $25,019,019.00. Following the completion of the acquisition, the chief executive officer now owns 679,493 shares of the company's stock, valued at $196,081,295.01. The trade was a 14.63% increase in their position. The purchase was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, Director Kristen Gil purchased 3,700 shares of UnitedHealth Group stock in a transaction dated Thursday, May 15th. The shares were bought at an average price of $271.17 per share, with a total value of $1,003,329.00. Following the completion of the acquisition, the director now directly owns 3,818 shares of the company's stock, valued at approximately $1,035,327.06. This represents a 3,135.59% increase in their ownership of the stock. The disclosure for this purchase can be found here. Insiders have acquired 109,408 shares of company stock valued at $31,607,768 over the last quarter. Corporate insiders own 0.28% of the company's stock.

Wall Street Analysts Forecast Growth

UNH has been the subject of a number of recent research reports. Oppenheimer dropped their target price on UnitedHealth Group from $600.00 to $400.00 and set an "outperform" rating for the company in a research report on Wednesday, May 14th. Truist Financial reaffirmed a "buy" rating and issued a $360.00 price objective (down previously from $580.00) on shares of UnitedHealth Group in a research note on Monday, May 19th. Erste Group Bank downgraded shares of UnitedHealth Group from a "strong-buy" rating to a "hold" rating in a research note on Wednesday, April 30th. Barclays reduced their price objective on UnitedHealth Group to $350.00 and set an "overweight" rating on the stock in a research note on Monday, June 2nd. Finally, Baird R W cut UnitedHealth Group from a "strong-buy" rating to a "hold" rating in a report on Wednesday, June 11th. One research analyst has rated the stock with a sell rating, nine have assigned a hold rating and sixteen have issued a buy rating to the stock. According to MarketBeat, UnitedHealth Group presently has an average rating of "Moderate Buy" and a consensus price target of $415.57.

UnitedHealth Group Stock Up 2.1%

Shares of NYSE UNH opened at $308.85 on Monday. The firm has a fifty day simple moving average of $336.21 and a two-hundred day simple moving average of $453.53. The firm has a market capitalization of $280.17 billion, a PE ratio of 12.93, a price-to-earnings-growth ratio of 1.46 and a beta of 0.45. The company has a current ratio of 0.85, a quick ratio of 0.85 and a debt-to-equity ratio of 0.71. UnitedHealth Group Incorporated has a 12 month low of $248.88 and a 12 month high of $630.73.

UnitedHealth Group (NYSE:UNH - Get Free Report) last issued its quarterly earnings data on Thursday, April 17th. The healthcare conglomerate reported $7.20 EPS for the quarter, missing the consensus estimate of $7.29 by ($0.09). UnitedHealth Group had a return on equity of 26.29% and a net margin of 5.39%. The company had revenue of $109.58 billion during the quarter, compared to analysts' expectations of $111.56 billion. During the same quarter last year, the business earned $6.91 earnings per share. Equities analysts expect that UnitedHealth Group Incorporated will post 29.54 earnings per share for the current year.

UnitedHealth Group Increases Dividend

The firm also recently declared a quarterly dividend, which was paid on Tuesday, June 24th. Investors of record on Monday, June 16th were paid a $2.21 dividend. This represents a $8.84 annualized dividend and a dividend yield of 2.86%. This is a positive change from UnitedHealth Group's previous quarterly dividend of $2.10. The ex-dividend date of this dividend was Monday, June 16th. UnitedHealth Group's dividend payout ratio (DPR) is presently 37.02%.

UnitedHealth Group Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.

Want to see what other hedge funds are holding UNH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for UnitedHealth Group Incorporated (NYSE:UNH - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.